1. Drug Safety Research Unit and pharmacoepidemiology

   • Saad Shakir
   • Lynda Wilton

   Editorial 23 December 2012 Pages: 1 - 2

2. Counting the costs of specialisation and of revalidation

   • Robert N. Smith

   Editorial 23 December 2012 Pages: 2 - 4

3. Where now for MMPIs?

   Commentary 23 December 2012 Pages: 5 - 6

4. Silicone gel breast implant controversy

   • Robert N. Smith

   Commentary 23 December 2012 Pages: 6 - 7

5. Death of a patient causes problems for gene therapy

   Commentary 23 December 2012 Pages: 7 - 8

6. The trials and tribulations of amylin

   Commentary 23 December 2012 Pages: 8 - 9

7. Announcements

   Announcement 23 December 2012 Pages: 11 - 11

8. South African Regulatory Legislation — an update

   • Kewn Sprenger

   News 23 December 2012 Pages: 13 - 13

9. Newappointments in Australia

   • John McEwen

   News 23 December 2012 Pages: 13 - 13

10. Faculty Fellowships and Memberships

    News 23 December 2012 Pages: 14 - 14

11. ICPM 2000 update

    News 23 December 2012 Pages: 14 - 14

12. Dr David Stanley Freestone

    Obituary 23 December 2012 Pages: 15 - 16

    

13. Defining the spectrum of appropriate prescribing: implications for effective medicines management

    • Martin Frischer
    • H. Heatlie
    • D. Millson

    Original Article 23 December 2012 Pages: 17 - 21

    

14. Good Clinical Practice and study monitoring: results of an Italian survey of the clinical monitor

    • Francesco De Tomasi
    • C. Zanna

    Original Article 23 December 2012 Pages: 23 - 25

    

15. Collaborative networks with private doctors to conduct joint clinical studies in Leipzig/Germany

    • Hans-Detlev Stahl
    • F. Emmrich

    Original Article 23 December 2012 Pages: 27 - 28

16. The development of quality assurance within the Medicines Control Agency

    • David B. Jefferys

    Original Article 23 December 2012 Pages: 29 - 32

    

17. Pharmaceutical medicine and academic clinical pharmacology: a convergent pathway?

    • Colin T. Dollery

    Point of View 23 December 2012 Pages: 33 - 36

18. Should serious adverse events requiring expedited regulatory reporting be unblinded?

    • John E. Gait
    • D. Goldsmith

    Point of View 23 December 2012 Pages: 37 - 39

19. Clinical standards and quality in the NHS

    • Liam J. Donaldson

    Lecture 23 December 2012 Pages: 41 - 46

    

20. Higher medical training in pharmaceutical medicine: Delphi exercise on drug safety surveillance and statistics and data management advanced modules

    • H. F. Boardman
    • D. S. Millson
    • M. J. Phelan

    Education 23 December 2012 Pages: 47 - 51

    

21. Annual report of the Board of Examiners

    Education 23 December 2012 Pages: 53 - 56

    

22. The Adrian Salter Lecture

    • Donna Ellender

    Society of Pharmaceutical Medicine 23 December 2012 Pages: 57 - 58

23. Pharmacogenetics Working Party

    Society of Pharmaceutical Medicine 23 December 2012 Pages: 58 - 58

24. First Report of the Ethics Sub-Group

    • Frank Wells
    • Martin W. Lunnon
    • Pharmacogenetics Working Party

    Society of Pharmaceutical Medicine 23 December 2012 Pages: 58 - 58